PITYRIASIS LICHENOIDES ET VARIOLIFORMIS ACUTA (PLEVA) DEVELOPED AFTER BIONTECH/PFIZER VACCINE: A CASE REPORT
Main Article Content
Abstract
Introduction: After nearly two years, there have been observational reports of skin reactions to COVID-19 vaccines so far. Cutaneous reactions after messenger RNA (mRNA) COVID-19 vaccines commonly includes early-onset local injection reactions, urticaria, and morbilliform eruptions. Pityriasis lichenoides et varioliformis acuta (PLEVA), one form of pityriasis lichenoides, is an uncommon cutaneous inflammatory disorder. This disease could appear after viral, bacterial infections and vaccinations. We describe a case of PLEVA following mRNA COVID-19 vaccine BioNTech/Pfizer at Dermatological clinic, National Children Hospital. Clinical case: A-13-year-old male patient with no history of systemic illness had multiple erythematous macules papules, some of which develop hemorrhagic or necrotic crusts at his back, chest and extremities after 2 weeks of 2nd BioNTech/Pfizer vaccination. Two days after emergence of cutaneous lesions, he was done biopsy with result: parapsoriasis, PLEVA. He was treated with high potency topical corticoid. Earlier lesions resolved and no new lesions appeared after 4 weeks.
Article Details
Keywords
Vảy phấn dạng lichen và đậu mùa cấp tính (PLEVA), vắc xin BioNTech/Pfizer
References
2. Bowers S.vàWarshaw E. M. (2006), Pityriasis lichenoides and its subtypes, J Am Acad Dermatol, 55(4), 557-72; quiz 573-6.
3. Dereure O., Levi E. và Kadin M. E. (2000), T-Cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases, Arch Dermatol, 136(12), 1483-6.
4. Jastrzab B. A., Stefaniak A. A., Hryncewicz-Gwozdz A. et al (2021), Pityriasis Lichenoides et Varioliformis Acuta Triggered by Human Papillomavirus Vaccine: A Case Report and Literature Review, Acta Derm Venereol, 101(9), adv00552.
5. Gianotti R., Restano L., Cutrone M. et al (2021), Papulo-purpuric dermatitis of childhood: a distinct PLEVA-like eruption associated to SARS-CoV-2 infection. Clinical, histopathological and immunohistochemical study of 10 cases, Pediatr Dermatol, 38(5), 1185-1190.
6. Sernicola A., Dybala A., Gomes V. et al (2021), Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption, J Eur Acad Dermatol Venereol.
7. Palmen J., Lepisto M., Talve L. et al (2022), Pityriasis lichenoides et varioliformis acuta following COVID-19 mRNA vaccination, J Eur Acad Dermatol Venereol.